307 Research Drive
Room 255B, Nanaline Duke Building
Durham, NC 27710
United States of America
Honors and awards
Dr. Andrews is Vice Chancellor for Academic Affairs and Dean Emerita, Duke University School of Medicine. She obtained her Ph.D. in Biology from M.I.T. and her M.D. from Harvard. She did her housestaff training at Children’s Hospital Boston and a pediatric hematology-oncology fellowship at Children’s Hospital and Dana-Farber Cancer Institute before joining the faculty. Prior to moving to Duke she served as the Dean for Basic Sciences and Graduate Studies at Harvard Medical School. Dr. Andrews' research laboratory focused on molecular hematology, mammalian iron homeostasis and mouse models of human diseases. Her group identified several novel proteins involved in normal iron handling through positional cloning of spontaneous mouse and rat mutations associated with iron deficiency. They have used gene targeting to disrupt iron-related genes in mice, to interrogate the details of iron homeostasis and to develop mouse models of hemochromatosis. Using these models, they have elucidated the roles of the iron-regulating hormone hepcidin in the pathogenesis of hemochromatosis and the anemia of inflammation. Dr. Andrews is also a member of the Association of American Physicians, the National Academy of Sciences, the National Academy of Medicine and the American Academy of Arts and Sciences. She currently serves as Chair of the Board of Directors for both the Burroughs Wellcome Fund and the American Academy of Arts and Sciences. She is a member of the MIT Corporation and on the Board of Directors of Novartis AG.
Duke University School of Medicine (Primary)
Scott M. Palmer, MD, MHS is the representative at this institution.
Duke University and Health System (Secondary)